24小时热门版块排行榜    

查看: 1136  |  回复: 3
本帖产生 1 个 翻译EPI ,点击这里进行查看
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

xiaotongxyz

木虫 (正式写手)

[交流] 求助翻译中文摘要一份,重赏金币,翻译的好可追加

原文:

国产利培酮治疗脑血管病所致精神障碍疗效分析

摘要:目的:探讨国产利培酮(思利舒)治疗脑血管病所致精神障碍疗效和安全性。方法:随机抽取脑血管病所致精神障碍30例,用思利舒治疗,并分别于治疗前及治疗后第1、2、4、8周末才去简明精神病量表(BPRS)、阳性症状阴性症状量表(PANSS)及副作用量表(TCSS)评定临床疗效及不良反应。结果:BPRS总分、PANSS总分和各症状评分均较治疗前显著降低,且有显著差异(P<0.01~0.05),有效率:90%,显效率:63%,常见不良反应是体重增加、静坐不能。结论:思利舒对脑血管所知精神障碍安全有效,不良反应少,经济适用,值得临床推广使用。
我不是一个随便的人,我随便起来不是人,哈哈
已阅   关注TA 给TA发消息 送TA红花 TA的回帖

pharmjackie

木虫 (正式写手)

xiaotongxyz(金币+30):前半部分翻译很好,后半部分不够理想,专业性再强些就好了 2010-04-30 01:22
efficacy of Risperidone on brain vascular diseases caused psychonosema

Abstract  Object: to evaluate the efficacy and safety of Risperidone on brain vascular diseases caused psychonosema. Method: A total of 30 patients with psychonosema was randomly selected to treat with Risperidone, and clinical efficacy and adverse effect was recorded using BPRS, PANSS, and TCSS before treatment and at the end of 1, 2, 4, 8 weeks after treatment. Results: BPRS scores, PANSS scores and symptom scores decreased significantly compared to that of pre-treatment (P<0.01~0.05). Effective percentage is 90% while the obvious effective rate is 63%. Common adverse effects include: Weight gain, akathisia. Conclusion: Risperidone’s effectiveness, safety and minor adverse effect makes itself worthy of clinical use.
3楼2010-04-29 22:10:21
已阅   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 4 个回答

非比寻常

木虫 (小有名气)

xiaotongxyz(金币+20, 翻译EPI+1):翻译的不够专业,有些翻译不够准确专业 2010-04-30 01:18
Analysis of therapeutic effect of domestic Risperidone on non-psychotic disorders
resulting from cerebrovascular diseases

Abstract:
Purpose: to probe into therapeutic effect and security of domestic Risperidone on non-psychotic disorders resulting from cerebrovascular diseases.
Approach: to randomly draw 30 cases with non-psychotic disorders resulting from cerebrovascular diseases, treat them with Risperidone and then assess clinical curative effects and undesirable reactions with BPRS, PANSS and TCSS at the end of the first, second, fourth and eighth week before and after treatment. Result: aggregate score of BPRS and PANSS and each symptom score are considerablely much lower than that before treatment with significant variation
(P<0.01~0.05). The effective rate is 90% and developing rate is 63%. Common undesirable reactions are gain in weight and loss of sitting still.
Conclusion: Risperidone is secure and effective with a few undesirable reactions and deserves promotion and application because of its economically affordable and applicable trait on the treatment of non-psychotic disorders resulting from cerebrovascular diseases.
学会取舍!
2楼2010-04-29 21:53:09
已阅   关注TA 给TA发消息 送TA红花 TA的回帖

xiaotongxyz

木虫 (正式写手)

求助结束,申请撤销帖子,退回金币

求助已解决,虽有答复,但是不满意结果,申请退回剩余金币
我不是一个随便的人,我随便起来不是人,哈哈
4楼2010-05-07 11:58:31
已阅   关注TA 给TA发消息 送TA红花 TA的回帖
信息提示
请填处理意见